Dr. James Mond
Equibles does not estimate personal net worth.
About Dr. James Mond
Adma Biologics, Inc. reported in an 8-K filed June 14, 2021 that Dr. James Mond resigned as Chief Medical Officer and Chief Scientific Officer, effective June 8, 2021. The proxy statement of Adma Biologics, Inc. reports total compensation of $1,195,348 for Dr. James Mond in fiscal 2020, including a base salary of $440,000. Disclosed compensation is on record for 3 fiscal years.
“On June 8, 2021, Dr. James Mond, M.D., Ph.D., Chief Medical Officer and Chief Scientific Officer, voluntarily resigned from ADMA Biologics, Inc. (the “Company”), effective immediately.”
Affiliation history
-
Adma Biologics, Inc. (ADMA)
Proxy statement
Start not stated–2021-06-08
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Adma Biologics, Inc. (ADMA) | Former Executive Vice President, Chief Scientific Officer and Chief Medical Officer | $440,000 | $1,195,348 |
| 2019 | Adma Biologics, Inc. (ADMA) | Executive Vice President, Chief Scientific Officer and Chief Medical Officer | $415,000 | $1,237,422 |
| 2018 | Adma Biologics, Inc. (ADMA) | Executive Vice President, Chief Scientific Officer and Chief Medical Officer | $401,800 | $1,045,449 |